Osteoporosis in the context of preventive measures
Authors:
I. Ondriová; T. Fertaľová; L. Hadašová
Authors‘ workplace:
Prešovská univerzita v Prešove, Fakulta zdravotníckych odborov, Dekanka: doc. PhDr. Štefánia Andraščíková, PhD., MPH Katedra ošetrovateľstva, Vedúca: PhDr. Terézia Fertaľová, PhD.
Published in:
Prakt. Lék. 2026; 106(2): 82-86
Category:
Of different specialties
Overview
Osteoporosis is defined as a progressive systemic skeletal disease characterized by loss of bone mass (both mineral and organic components) and impaired bone microarchitecture, resulting in increased susceptibility to fractures. The most common fractures are osteoporotic fractures, especially in the forearm and vertebrae, and the most serious is a femoral neck fracture, which is the cause of death within one year of injury in about 20%. These fractures often occur after an unreasonably minor injury or even spontaneously. In the present article, the authors pay attention to the issue of osteoporosis in the context of preventive measures.
Keywords:
prevention – osteoporosis – causes – manifestations
Sources
1. Brown JP. Long-term treatment of postmenopausal osteoporosis. Endocrinol Metab. (Seoul) 2021; 36(3): 544–552.
2. Coughlan T, Dockery F. Osteoporosis and fracture risk in older people. Clin Med. (London) 2014; 14(2): 187–191.
3. Edmonds SW, Solimeo SL, Nguyen VT, et al. Understanding preferences for osteoporosis information to develop an osteoporosis patient education brochure. Perm J. 2017; 21 : 16–24.
4. Gao S, Zhao Y. Quality of life in postmenopausal women with osteoporosis: a systematic review and meta-analysis. Qual Life Res. 2023; 32(6): 1551–1565.
5. Gosset A, Pouillès JM, Trémollieres F. Menopausal hormone therapy for the management of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2021; 35(6): 101551.
6. Jung HJ, Im SS, Song DK, Bae JH. Effects of chlorogenic acid on intracellular calcium regulation in lysophosphatidylcholine-treated endothelial cells. BMB Rep. 2017; 50(6): 323–328.
7. Kwak HB, Lee SW, Li YJ, et al. Inhibition of osteoclast differentiation and bone resorption by a novel lysophosphatidylcholine derivative, SCOH. Biochem Pharmacol. 2004; 67(7): 1239–1248.
8. Liu B, Shi J, Li Z, et al. Study on neuroendocrine-immune function of Cistanche deserticola and its rice wine steaming products in glucocorti-coid-induced rat model. Evid Based Complement Altern Med. 2020; 2020 : 5321976.
9. Muñoz M, Robinson K, Shibli-Rahhal A. Bone health and osteoporosis prevention and treatment. Clin Obstet Gynecol. 2020; 63(4): 770–787.
10. Ompusunggu IHR. A comprehensive literature review of osteoporosis treatment and fracture outcomes. Indonesian Journal of General Medicine 2024; 7(4): 16–29.
11. Sheik Ali A. Osteoporosis: A Narrative Review. Cureus 2023; 15(8): e43031.
12. Srivastava M, Deal C. Osteoporosis in elderly: prevention and treatment. Clin Geriatr Med. 2002; 18(3): 529–555.
13. Testini V, Paparella MT, Gangai I, Guglielmi G. Postmenopausal osteoporosis: current status of bone densitometry. Minerva Obstet Gynecol. 2021; 73(6): 730–743.
14. Yang S, Feskanich D, Willett WC, et al. Association between global biomarkers of oxidative stress and hip fracture in postmenopausal women: a prospective study. Bone Miner Res. 2014; 29(12): 2577–2583.
15. Yong EL, Logan S. Menopausal osteoporosis: screening, prevention and treatment. Singapore Med J. 2021; 62(4): 159–166.
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
2026 Issue 2
Most read in this issue
- Is lipoprotein(a) testing relevant in cardiovascular risk stratification?
- Pokyny pro autory časopisu Praktický lékař Časopis pro další vzdělávání lékařů
- Use of modern bioanalytical methods to determine the composition of solid biological samples
- Level of awareness of women about HPV vaccination by age of women